Necessity of repeat biopsies in men for suspected prostate cancer

International Journal of Urology

Volumn 6, Issue 1, 1999, Pages 7-12

  Noguchi, Masanori ^a   Yahara, Junro ^a   Koga, Hiroshi ^a   Nakashima, Osamu ^a   Noda, Shinshi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biopsy; Prostate specific antigen; Prostatic cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DENSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; ORGAN SIZE; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SAMPLING; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES;

EID: 0033513493     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.1999.00611.x     Document Type: Article

References (28)

1. 1 Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal exam and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men. J. Urol. 1994; 151: 1283-90.
2. 2 Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J. Urol. 1994; 152: 1732-6.
3. 3 Oesterling JE. Prostate specific antigen: Its role in the diagnosis and staging of prostate cancer. Cancer 1995; 75: 1795-804.
4. 4 Benson MC, Whang IS, Pantuck A et al. Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol. 1992; 147: 815-16.
5. 5 Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol. 1992; 147: 817-21.
6. 6 Benson MC, Whang IS, Cooner WH, Olsson CA. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density. World J. Urol. 1993; 11: 206-13.
7. 7 Smith DS, Catalona WJ. Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J. Urol. 1994; 152: 1163-7.
8. 8 Carter HB, Pearson JD, Metter EJ et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992; 267: 2215-20.
9. 9 Brawer MK, Bigler SA, Sohlberg OE, Nagle RB, Lange PH. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology 1991; 38: 103-7.
10. 10 Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol. 1989; 142: 71-5.
11. 11 Dargo JR, Mostofi FK, Lee F. Introductory remarks and workshop summary. Urology 1989; 34 (Suppl.): 2-3.
12. 12 Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 year. J. Urol. 1994; 152: 1831-6.
13. 13 Albertsen PC. Early stage prostate cancer. When is observation appropriate? Hematol. Oncol. Clin. North Am. 1996; 10: 611-25.
14. 14 Nadler RB, Andriole GL. Who is best benefited by radical prostatectomy? Hematol. Oncol. Clin. North Am. 1996; 10: 581-93.
15. 15 Jenson CB, Shahon DB, Wangensteen OH. Evaluation of annual examination in the detection of cancer. Special reference to cancer of the gastrointestinal tract, prostate, breast, and female generative tract. JAMA 1960; 174: 1783-8.
16. 16 Thompson IM, Ernst JJ, Gangai MP, Spence CR. Adenocarcinoma of the prostate: Results of routine urological screening. J. Urol. 1984; 132: 690-2.
17. 17 Chodak GW, Keller P, Schoenberg HW. Assessment of screening for prostate cancer using the rectal examination. J. Urol. 1989; 141: 1136-8.
18. 18 Catalona WJ, Smith DS, Ratliff TL et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991; 324: 1156-61.
19. 19 Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J. Urol. 1992; 147: 841-5.
20. 20 Rommel FM, Agusta VE, Breslin JA et al. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J. Urol. 1994; 151: 88-93.
21. 21 Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J. Urol. 1994; 151: 1571-4.
22. 22 Ellis WJ, Brawer MK. Repeat prostate needle biopsy: Who needs it? J. Urol. 1995; 153: 1496-8.
23. 23 Brawer MK, Aramburu EAG, Chen GL, Preston SD, Ellis WJ. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J. Urol. 1993; 150: 369-73.
24. 24 Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ. Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. J. Urol. 1996; 156: 428-31.
25. 25 Brawer MK, Bigler SA, Sohlberg OE, Nagle RB, Lange PH. Significance of prostatic intraepitherial neoplasia on prostate needle biopsy. Urology 1991; 38: 103-7.
26. 26 Weinstein MH, Epstein JI. Significance of high-grade prostatic intraepitherial neoplasia on needle biopsy. Hum. Pathol. 1993; 24: 624-9.
27. 27 Aboseif S, Shinohara N, Weidner N, Narayan P, Carroll PR. The significance of prostatic intra-epithelial neoplasia. Br. J. Urol. 1995; 76: 355-9.
28. 28 Davidson D, Bostwick DG, Qian J et al. Prostatic intraneoplasia is a risk factor for adenocarcinoma: Predictive accuracy in needle biopsies. J. Urol. 1995; 154: 1295-9.